Summary
Amiflamine is a selective and reversible inhibitor of monoamine oxidase (MAO) type A which exerts a preferential effect on serotonin (5-HT) catabolism. The present studies were undertaken to compare the effects of repeated administration of amiflamine (2 mg/kg, twice daily) on several aspects of the functioning of the 5-HT and norepinephrine (NE) systems in the rat CNS. The activity of MAO-A and B was assessed in forebrain slices and the whole brain contents of the neurotransmitters and their metabolites were determined by HPLC after 2-, 7- and 21-day treatments. MAO-A was inhibited by about 50% 2 h after the last dose and its activity was back to normal in rats sacrificed 12 h after the last dose. The activity of MAO-B was unaffected two or 12 h after the last dose. Whole brain concentration of 5-HT was increased to a greater degree than that of NE following repeated administration of amiflamine. These increases in 5-HT and NE were accompanied by decreased levels of their respective metabolites 5-hydroxy-indoleacetic acid and 3-methoxy-4-hydroxyphenylethyleneglycol. The firing activity of dorsal raphe 5-HT neurons, but not that of NE neurons, was markedl decreased 2–6 h after the last dose of a 2-day treatment. However, 2–6 h after a 21-day treatment, the firing activity of 5-HT neurons was back to normal, whereas that of NE neurons was decreased by 30%. The recovery of firing activity of 5-HT neurons following long-term amiflamine is attributable to a desensitization of the somatic 5-HT autoreceptor as indicated by the decreased responsiveness of 5-HT neurons to intravenous LSD. In contrast, the sensitivity of the somatic NE autoreceptor was not modified, as verified by the unchanged responsiveness of NE neurons to clonidine, an α2 agonist. The duration of the suppression of firing activity of hippocampus pyramidal neurons produced by the electrical activation of the ascending 5-HT pathway was prolonged in amiflamine-treated rats as compared to controls. This increased synaptic efficacy was attributable to a presynaptic modification since the responsiveness of the same neurons to microiontophoretically-applied 5-HT was not changed. The efficacy of the stimulation of the dorsal NE bundle, as well as that of the microiontophoretic applied of NE, were unchanged in the same rats. Since the efficacy of the stimulation of the 5-HT pathway is increased at the time 5-HT neurons have regained their normal firing rate, it is concluded that 5-HT neurotransmission is enhanced following the long-term treatment with amiflamine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aghajanian, GK (1978) Feedback regulation of central monoaminergic neurons: evidence from single cell recording studies. In: Youdim MBH, Lovenberg W, Sharman DF, Lagnado JR (eds) Essays in neurochemistry and neuropharmacology, vol 3. John Wiley, New York, pp 1–33
Ask AL, Hellstrom W, Norrman S, Ögren SO, Ross SB (1982) Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-α-methylphenylalkylamine derivatives in the rat. Neuropharmacology 21:299–308
Ask AL, Fagervall I, Jonze M, Kelder D, Nygren R, Ross SB (1984) Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat. Biochem Pharmacol 33:2839–2847
Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355–363
Baraban JM, Wang RY, Aghajanian GK (1978) Reserpine suppression of dorsal raphe neuron firing: mediation by adrenergic system. Eur J Pharmacol 52:27–36
Blier P, de Montigny C (1983) Electrophysiological investigations on the effect of repeated zimelidine administration of serotonergic neutransmission in the rat. J Neurosci 3:1270–1275
Blier P, de Montigny C (1985) Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 16:949–955
Blier P, de Montigny C, Azzaro AJ (1986) Modification of serotonergic and noradrenergic neurotransmission by repeated administration of monoamine oxidase inhibitors. Electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 237:987–994
Blier P, de Montigny C, Tardif D (1984) Effects of the two antidepressant drugs mianserin and indalpire on the serotonergic system: single-cell studies in the rat. Psychopharmacology 84:242–249
Casacchia M, Carolei A, Barba C, Rossi A (1984) Moclobemide (RO 11-1163) versus placebo: A double-blind study in depressive patients. In: Tipton KF, Dostert P, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic Press, New York, pp 607–608
Cedarbaum JM, Aghajanian GK (1977) Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. Eur J Pharmacol 44:375–385
Chaput Y, de Montigny C, Blier P, (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological study in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol (in press)
de Montigny C, Aghajanian GK (1977) Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: a comparative iontophoretic study with LSD and 5-HT. Neuropharmacology 16:811–818
Haigler HJ, Aghajanian GK (1974) Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. J Pharmacol Exp Ther 188:688–699
Hartman BK (1975) The central adrenergic system. An immunofluorescence study of the localization of cell bodies and their efferent connections in the rat utilizing dopamine-β-hydroxylase as a marker. J Comp Neurol 163:467–506
Hegstrand LR, Eichelman B (1981) Determination of rat brain tissue catecholamines using liquid chromatography with electrochemical detection. J Chromatog 222:107–111
Herd JA (1969) A new antidepressant-M and B 9302. A pilot study and a double-blind controlled trial. Clin Trials 6:219–225
Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17:1285–1297
Kandel ER, Spencer WA (1961) Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol 24:243–259
Knoll J (1976) Analysis of the pharmacological effects of selective monoamine oxidase inhibitors. In: Wolstenholme GEW, Knight J (eds) Monoamine oxidase and its inhibition. Elsevier, Amsterdam, pp 135–161
Kunimoto N, Mazama H, Kamase H (1979) Regional distribution of type B MAO activity toward β-phenylethylamine in the individual rat hypothalamus nuclei. Brain Res 176:175–189
Lipper S, Murphy DL, Slater S, Buchsbaum MS (1979) Comparative behavioral effects of clorgyline and paragyline in man: a preliminary evaluation. Psychopharmacology 62:123–128
Mann JJ, Fox-Aarons S, Frances A, Bernstein W, Brown RD (1984) Studies of selective and reversible monoamine oxidase inhibitors. J Clin Psychiat 45:62–66
Murphy DL, Lipper S, Pickar D, Jimerson D, Cohen RM, Garrick NA, Alterman IS, Campbell IC (1981) Selective inhibition of monoamine oxidase type A: clinical antidepressant effects of metabolic changes in man. In: Youdim MBH, Paykel ES (eds) Monoamine oxidase inhibitors — the state of the art. John Wiley, New York, pp 189–205
Olpe HR, Schellenburg A (1981) The sensitivity of cortical neurons to serotonin: Effect of chronic treatment with antidepressants, serotonin uptake inhibitors and monoamine oxidase blocking drugs. J Neural Transm 51:233–244
Olpe HR, Schellenburg A (1984) The sensitivity of hippocampal pyramidal neurons to serotonin in vitro: Effect of prolonged treatment with clorgyline or clorimipramine. J Neural Transm 60:265–271
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New York
Standish-Barry H, Sim ACP, Olsson B, Rix K (1985) On open label study of amiflamine — a selective MAO-A inhibitor — in depressive illness. IVth World Cong Biol Psychiat 4:194
Stefanis CN, Alevizos B, Papadimitriou GN (1984) Controlled clinical study of moclobemide (RO-11-1163), a new MAO inhibitor, and desipramine in depressive patients. In: Tipton KF, Dostert P, Strolin-Benedetti M (eds.). Academic Press, New York, pp 377–392
Westerink BHC (1984) Determination of normetanephrine, 3,4-dihydroxyphenylethyleneglycol (free and total), and 3-methoxy-4-hydroxyphenylethyleneglycol (free and total) in rat brain by high performance liquid chromatography with electrochemical detection and effects of drugs on regional concentrations. J Neurochem 42:934–942
Wheatley D (1970) Comparative trial of a new monoamine oxidase inhibitor in depression. Br J Psychiatr 117:573–574
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blier, P., de Montigny, C. & Azzaro, A.J. Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: Electrophysiological studies in the rat CNS. Naunyn-Schmiedeberg's Arch. Pharmacol. 334, 253–260 (1986). https://doi.org/10.1007/BF00508779
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00508779